Commentary
Fed. Circ. OKs Boston Drug Developer's Patent Win Fed. Circ. OKs Boston Drug Developer's Patent Win
March 11, 2024
Law360Commentary
Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel
November 21, 2023
Managing Intellectual PropertyAward/Ranking
Finnegan Upholds Tier 1 Marks in 2023 LMG Life Sciences Rankings Finnegan Upholds Tier 1 Marks in 2023 LMG Life Sciences Rankings
September 21, 2023
LMG Life SciencesAward/Ranking
Finnegan Shortlisted in 10 Categories in the LMG Life Sciences Awards 2023 Finnegan Shortlisted in 10 Categories in the LMG Life Sciences Awards 2023
July 25, 2023
LMG Life SciencesMedia Mention
Biogen MS Drug Patent Survives Mylan's PTAB Challenge Biogen MS Drug Patent Survives Mylan's PTAB Challenge
February 6, 2020
Law360Media Mention
PTAB Axes Hair Loss Treatment Patent In Incyte Challenge PTAB Axes Hair Loss Treatment Patent In Incyte Challenge
April 9, 2019
Law360Press Release
Finnegan Partners Recognized for Commitment to Client Service Finnegan Partners Recognized for Commitment to Client Service
February 8, 2018
Media Mention
PTAB 4 Years In: Biotech/Pharma's Share of AIA Trials Increases PTAB 4 Years In: Biotech/Pharma's Share of AIA Trials Increases
September 16, 2016
Managing Intellectual PropertyMedia Mention
America Invents Act Post-Grant Oppositions After Two Years: A Case End-to-End: What Wins? What Loses? America Invents Act Post-Grant Oppositions After Two Years: A Case End-to-End: What Wins? What Loses?
September 23, 2014
Bloomberg BNAMedia Mention
Cephalon Beats Challenge to Narcolepsy Drug Patent Cephalon Beats Challenge to Narcolepsy Drug Patent
April 1, 2013
Law360Press Release
District Court Rules in Favor of Finnegan Client Cephalon to Uphold Patent for Nuvigil® District Court Rules in Favor of Finnegan Client Cephalon to Uphold Patent for Nuvigil®
March 30, 2013
Media Mention
Cumberland Seeks to Block Perrigo's Generic Acetadote® Cumberland Seeks to Block Perrigo's Generic Acetadote®
August 10, 2012
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.